2seventy bio Reports First Quarter Financial Results and Recent Operational Progress

Author's Avatar
May 03, 2023

2seventy+bio%2C+Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy Company, today reported financial results and recent highlights for the first quarter ended March 31, 2023.